Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Arix Bioscience

Arix Bioscience
VC INVESTOR TYPE
Active STATUS
7 PROFESSIONALS
26 INVESTMENTS
18 PORTFOLIO
4 EXITS
Description

Arix Bioscience is a venture capital firm founded in 2015 and is based in London, United Kingdom. The firm sources, finances and develops both start-up and later-stage companies across healthcare and life science sectors supporting medical innovation globally.

Investor Status
Actively Seeking New Investments
Year Founded
2015
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 20 Berkeley Square
  • London W1J 6EQ
  • England, United Kingdom

+44 020 0000 0000

Arix Bioscience Investments & Acquisitions (26)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Amplyx 09-Jan-2020 Later Stage VC 00000 Pharmaceuticals Generating Revenue 000000 00000000 00.0
00000 000000000000 30-Sep-2019 00000 00000 0000 Drug Delivery Startup 00000000 00000 00.0
0000 000 30-Apr-2019 00000 00000 0000 Biotechnology Clinical Trials - General 00000000 00000 00.0
0000 00000000000 02-Apr-2019 00000 00000 0000 Biotechnology Clinical Trials - Phase 1 0000 0000
00000 18-Mar-2019 00000 00000 0000 Biotechnology Clinical Trials - Phase 2 0000 0000
0000000 0000000000 08-Feb-2019 000 0000 Biotechnology Generating Revenue/Not Profitable 0000 0000
0000 00000000000 13-Dec-2018 00000 00000 000.00 Biotechnology Clinical Trials - Phase 1 0000 0000
0000000 0000000000 11-Nov-2018 00000 00000 0000 Biotechnology Generating Revenue/Not Profitable 0000 0000
Artios 09-Aug-2018 Early Stage VC 0000 Drug Discovery Generating Revenue 00000000 00000 00.0
BioMotiv 23-Jul-2018 Later Stage VC 00000 Drug Discovery Generating Revenue
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Arix Bioscience’s full profile, request a free trial.

Arix Bioscience Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
LogicBio Therapeutics 19-Oct-2018 IPO 0000 Completed
000000 00000000000 25-May-2018 000 0000 Completed
Verona Pharma 26-Apr-2017 Public Investment 2nd Offering 0000 Completed
Autolus Secondary Transaction - Open Market Completed
To view this investor’s complete exits history, request access »

Arix Bioscience Team (14)

Name Title Deals Funds Boards Office Contact
Info
Joseph Anderson Ph.D Chief Executive Officer 00 0 0 London, United Kingdom
Robert Lyne Chief Operating Officer & General Counsel London, United Kingdom
Jonathan Tobin Ph.D Investment Director 0 0 0 London, United Kingdom
Mark Chin Investment Director 0 0 New York, NY
John Cassidy Ph.D Investment Associate 0 London, United Kingdom

7 Former Team Members

You’re viewing 5 of 14 team members. Get the full list »